Wenjing Sun
- Hepatology top 5%
- Immunology top 10%
- interferon and immune responses 4
- Cancer Research top 10%
- NF-κB Signaling Pathways 5
- Molecular Biology top 10%
- Receptor Mechanisms and Signaling 4
- Microbiology top 5%
-
- Liver Disease Diagnosis and Treatment 6
-
- Nanoplatforms for cancer theranostics 5
-
- Polysaccharides and Plant Cell Walls 4
-
- Diet and metabolism studies 3
-
- Neuropeptides and Animal Physiology 3
- Cited by
- HepatologyImmunologyCancer Research
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Wenjing Sun
61 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 120
- Hepatology 154
- Immunology 333
- Cancer Research 236
- Molecular Biology 859
- Microbiology 73
Countries citing papers authored by Wenjing Sun
This map shows the geographic impact of Wenjing Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjing Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjing Sun more than expected).
Fields of papers citing papers by Wenjing Sun
This network shows the impact of papers produced by Wenjing Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjing Sun. The network helps show where Wenjing Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenjing Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 15 | |
| 6 | 2023 | 9 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 22 | |
| 11 | 2021 | 61 | |
| 12 | 2021 | 10 | |
| 13 | 2020 | 25 | |
| 14 | 2019 | 103 | |
| 15 | 2018 | 31 | |
| 16 | 2017 | 35 | |
| 17 | 2012 | 5 | |
| 18 | 2011 | 2 | |
| 19 | 2009 | 86 | |
| 20 | 2007 | 26 |
About Wenjing Sun
Wenjing Sun is a scholar working on Gastroenterology, Cancer Research and Hepatology, having authored 66 papers that have together received 1.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Nanoplatforms for cancer theranostics (5 papers), NF-κB Signaling Pathways (5 papers), interferon and immune responses (4 papers), Receptor Mechanisms and Signaling (4 papers), Polysaccharides and Plant Cell Walls (4 papers), Diet and metabolism studies (3 papers) and Neuropeptides and Animal Physiology (3 papers). The work is most often cited by research in Hepatology (154 citations), Immunology (333 citations) and Cancer Research (236 citations). Wenjing Sun has collaborated with scholars based in China, United States and France. Frequent co-authors include Dongfeng Chen, Yanling Wei, Jianhua Yang, Yi Shi, Gufeng Xu, Xiaolian Sun, Hongli Cui, Jun Qin, Yang Yang and Xiaohong Chen. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.